These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11269152)

  • 21. Evolution and treatment of childhood chronic inflammatory polyneuropathy.
    Rossignol E; D'Anjou G; Lapointe N; Haddad E; Vanasse M
    Pediatr Neurol; 2007 Feb; 36(2):88-94. PubMed ID: 17275659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis and treatment of inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA
    Acta Neurol Belg; 2000 Sep; 100(3):167-70. PubMed ID: 11098290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical condition of chronic inflammatory demyelinating polyneuropathy (CIDP).
    Phillips LH
    Muscle Nerve; 2009 Apr; 39(4):v-vii. PubMed ID: 19418620
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kissel JT
    Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
    Peltier AC; Donofrio PD
    Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series.
    McMillan HJ; Kang PB; Jones HR; Darras BT
    Neuromuscul Disord; 2013 Feb; 23(2):103-11. PubMed ID: 23140945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of chronic inflammatory demyelinating polyradiculoneuropathy presenting recurrent attacks associated with pregnancies].
    Shiraishi N; Kinoshita M; Shimizu M; Sumikura H; Fukada K
    Rinsho Shinkeigaku; 2018 Feb; 58(2):127-130. PubMed ID: 29386496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiological and clinical aspects of CIDP].
    Viala K
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S31-5. PubMed ID: 18087227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
    Ryan M; Ryan SJ
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Guimarães-Costa R; Iancu Ferfoglia R; Viala K; Léger JM
    Rev Neurol (Paris); 2014 Oct; 170(10):595-601. PubMed ID: 25200479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2010 Mar; 15(1):1-9. PubMed ID: 20433600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
    Saperstein DS; Barohn RJ
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA
    Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.
    Berger AR; Bradley WG; Brannagan TH; Busis NA; Cros DP; Dalakas MC; Danon MJ; Donofrio P; Engel WK; England JD; Feldman EL; Freeman RL; Kinsella LJ; Lacomis D; Latov N; Menkes DL; Sander HW; Thomas FP; Triggs WJ; Windebank AJ; Wolfe GI;
    J Peripher Nerv Syst; 2003 Dec; 8(4):282-4. PubMed ID: 14641652
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.
    Malik A; Berry R; Fung BM; Tabibian JH
    Clin J Gastroenterol; 2021 Feb; 14(1):1-13. PubMed ID: 33146871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.
    Kuitwaard K; van Doorn PA
    Drugs; 2009 May; 69(8):987-1001. PubMed ID: 19496628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.